Survivorship and Outcomes of Robotically Assisted Patellofemoral UKA
1 other identifier
observational
40
1 country
2
Brief Summary
The purpose of the study is to determine the survivorship rate of robotically guided isolated patellofemoral implants at 2, 5 and 10 year postoperative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2013
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 17, 2013
CompletedFirst Posted
Study publicly available on registry
September 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedSeptember 5, 2018
September 1, 2018
10 years
September 17, 2013
September 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
10 year survivorship of robotically guided isolated patellofemoral implants.
10 year survivorship of robotically guided isolated patellofemoral implants at 2,5, and 10 year follow up.
10 years after surgery
Secondary Outcomes (2)
2 year survivorship of robotically guided isolated patellofemoral implants.
2 years after surgery
5 year survivorship of robotically guided isolated patellofemoral implants.
5 years after surgery
Study Arms (1)
Patellofemoral Knee Arthroplasty
Patient who have received a robotically guided isolated patellofemoral implant.
Interventions
A robot guided isolated patellofemoral unicompartmental knee arthroplasty procedures to replace only the patellofemoral component of the knee.
Eligibility Criteria
Patients who underwent a primary robotically guided UKA and received an isolated patellofemoral implant.
You may qualify if:
- Over 21 years of age underwent primary robotically guided UKA and received an isolated patellofemoral implant at least 24 months post operative as of February 2013
You may not qualify if:
- Patient will be excluded from participation in the study if they are cognitively unable to answer study questions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
St. Helena Hospital Coon Joint Replacement Institute
St. Helena, California, 94574, United States
Rebound Orthopedics and Neurosurgery
Vancouver, Washington, 98686, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Thomas Coon, MD
St. Helena Hospital Coon Joint Replacement
- PRINCIPAL INVESTIGATOR
Todd Borus, MD
Rebound Orthopedics and Neurosurgery
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2013
First Posted
September 20, 2013
Study Start
February 1, 2013
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
September 5, 2018
Record last verified: 2018-09